Connection
John Messenger to Long Term Adverse Effects
This is a "connection" page, showing publications John Messenger has written about Long Term Adverse Effects.
|
|
Connection Strength |
|
|
|
|
|
0.131 |
|
|
|
-
Dasari TW, Saucedo JF, Krim S, Alkhouli M, Fonarow GC, Alvarez R, Ibrahim H, Dai D, Wang TY, Costa M, Lindenfeld J, Messenger JC. Clinical characteristics and in hospital outcomes of heart transplant recipients with allograft vasculopathy undergoing percutaneous coronary intervention: Insights from the National Cardiovascular Data Registry. Am Heart J. 2015 Dec; 170(6):1086-91.
Score: 0.131